Is the third component of metabolic syndrome really predictive of outcomes in type 2 diabetic patients?

Diabetes Care. 2006 Nov;29(11):2515-7. doi: 10.2337/dc06-0330.

Authors

Matteo Monami¹, Lorella Lambertucci, Andrea Ungar, Maria Pieri, Giulio Masotti, Niccolò Marchionni, Edoardo Mannucci

Affiliation

¹ Department of Critical Care Medicine and Surgery, Unit of Gerontology and Geriatrics, University of Florence and Azienda Ospedaliera Careggi, Via delle Oblate 4, 50134 Florence, Italy.

PMID: 17065696
DOI: 10.2337/dc06-0330

No abstract available

MeSH terms

Aged
Blood Pressure
Diabetes Mellitus, Type 2 / diagnosis*
Diabetes Mellitus, Type 2 / mortality*
Diabetes Mellitus, Type 2 / therapy
Female
Humans
Hyperglycemia / diagnosis
Hyperglycemia / mortality
Hyperglycemia / therapy
Hypertriglyceridemia / diagnosis
Hypertriglyceridemia / mortality
Hypertriglyceridemia / therapy
Insulin Resistance
Male
Metabolic Syndrome / diagnosis*
Metabolic Syndrome / mortality*
Metabolic Syndrome / therapy
Middle Aged
Morbidity
Predictive Value of Tests
Registries
Risk Factors